Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / En GPC3 målretting Bispecific antistoff,…
JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content.

JoVE Journal Cancer Research
En GPC3 målretting Bispecific antistoff, GPC3-S-Fab, med potente cytotoksisitet
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Journal (Cancer Research)
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Journal (Cancer Research)
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
 
Click here for the English version

En GPC3 målretting Bispecific antistoff, GPC3-S-Fab, med potente cytotoksisitet

Article DOI: 10.3791/57588-v • 11:13 min • July 12th, 2018
July 12th, 2018 •
1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2
1School of Pharmaceutical Sciences, Sun Yat-Sen University, 2Center for Cellular & Structural Biology, Sun Yat-Sen University

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Her presenterer vi en protokoll for å produsere en bispecific antistoff GPC3-S-Fab Escherichia coli. Det rensede GPC3-S-Fab har potente cytotoksisitet mot GPC3 positive lever kreftceller.

Tags

Kreftforskning problemet 137 Bispecific antistoff antistoff enkelt domene VHH GPC3-S-Fab GPC3 leverkreft
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter